Head-to-head · free
Elevance Health Inc. vs Faeth Therapeutics, Inc.
ELV vs FTH — return on capital, cash generation, margins and balance sheet side by side.
ELV
3 / 3
measures where ELV leads
FTH
0 / 3
measures where FTH leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | ELV · FY2025 | FTH · FY2025 |
|---|---|---|
| Revenue | $199.1B | — |
| Net income | $5.7B | (21.1M) |
| Revenue growth (yearly, multi-year) | 9.5% | — |
| Free cash flow | $3.2B | (20.5M) |
| Free cash flow margin | 1.6% | — |
| Net cash / (debt) | — | — |
| ROIC | — | — |
| Return on equity | 13.3% | -74.0% |
| Gross margin | — | — |
| Operating margin | — | — |
| Net debt / EBITDA | — | 0.39x |
Figures are as reported by each company; latest fiscal year shown.
Where Elevance Health Inc.'s cash went (FY2025)
- Capital spending
- $1.1B
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Faeth Therapeutics, Inc.'s cash went (FY2025)
- Capital spending
- $16000
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free